CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
  Liver News - REUTERS   Congress Calendar   Physician Resources  
High-risk coronary plaque linked to common liver disease
GSK hepatitis C shot shows promise, bodes well for Ebola vaccines
Sofosbuvir-ledipasvir effective for relapsed HCV-1
Individual genetic differences may affect Ebola survival - study
View Complete News Library
View all Congresses
  Featured Abstracts          
Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C
The continuum of hepatitis C testing and care
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
Pharmacokinetics, safety, and tolerability of faldaprevir in patients with renal impairment
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care
Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013
Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
Non-invasive assessment of liver fibrosis in chronic hepatitis B
Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort
Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
FOUR Score, a Reliable Score for Assessing Overt Hepatic Encephalopathy in Cirrhotic Patients
MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy
Metformin does not improve survival in patients with hepatocellular carcinoma
Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
Systemic Therapy for Hepatocellular Carcinoma: The Issue of Treatment Stage Migration and Registration of Progression Using the BCLC-Refined RECIST
Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage - a hospital based linkage study
          View All Abstracts  
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.